1,541 results on '"Van Gelder, Isabelle C"'
Search Results
2. Ancillary pharmacological treatment options
3. Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial
4. Atrial fibrillation: better symptom control with rate and rhythm management
5. Epidemiology and modifiable risk factors for atrial fibrillation
6. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials
7. Mobile app-based symptom-rhythm correlation assessment in patients with persistent atrial fibrillation
8. Dyspnea in patients with atrial fibrillation: Mechanisms, assessment and an interdisciplinary and integrated care approach
9. Association between comorbidities and left and right atrial dysfunction in patients with paroxysmal atrial fibrillation: Analysis of AF-RISK
10. High heart rates during paroxysmal atrial fibrillation: continuous rhythm monitoring data of the RACE V study.
11. Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry
12. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial
13. Author Correction: Epidemiology and modifiable risk factors for atrial fibrillation
14. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD)
15. Risk Factors for Atrial Fibrillation Progression
16. Abstract 12420: Orally Inhaled Flecainide for the Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm: Final Results From the Phase 2 Instant Trial
17. Managing elderly patients with atrial fibrillation and multimorbidity: call for a systematic approach.
18. Previous Exercise Levels and Outcome in Patients with New Atrial Fibrillation: "Past Achievements Do Not Predict the Future".
19. Effects of a simple cardiac rehabilitation program on improvement of self-reported physical activity in atrial fibrillation – Data from the RACE 3 study
20. Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective
21. Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
22. Longer and better lives for patients with atrial fibrillation : the 9th AFNET/EHRA consensus conference
23. Longer and better lives for patients with atrial fibrillation:the 9th AFNET/EHRA consensus conference
24. Cardioversion strategy impacts rate control during recurrences in patients with paroxysmal atrial fibrillation:A subanalysis of the RACE 7 ACWAS trial
25. Unexplained Atrial Myopathy and Sick Sinus Syndrome in a Young Patient with Atrial Fibrillation
26. Segment length in cine (SLICE) strain analysis: a practical approach to estimate potential benefit from cardiac resynchronization therapy
27. Dynamic biomarker profiles in patients with paroxysmal atrial fibrillation: Assessing the differences between sinus rhythm and acute atrial fibrillation episode
28. Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome
29. Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm
30. Multimorbidity in patients with atrial fibrillation.
31. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials
32. Women have less progression of paroxysmal atrial fibrillation: data from the RACE V study
33. Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey)
34. Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT)
35. Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
36. Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation
37. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
38. Cardioversion strategy impacts rate control during recurrences in patients with paroxysmal atrial fibrillation: A subanalysis of the RACE 7 ACWAS trial
39. Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
40. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume
41. Safety and efficacy of antiarrhythmic drugs
42. Contributors
43. Rate control of atrial fibrillation
44. Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop
45. Abstract 15742: An Open-label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution Shows Acute Conversion of Recent-onset, Symptomatic Atrial Fibrillation to Sinus Rhythm in a Dose- and Concentration-dependent Manner
46. Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation
47. Atrial Fibrillation During Cardiac Resynchronization Therapy
48. Renal sympathetic denervation induces changes in heart rate variability and is associated with a lower sympathetic tone
49. Sex Differences in Early Rhythm Control of Atrial Fibrillation in the EAST-AFNET 4 Trial
50. Multi-ethnic genome-wide association study for atrial fibrillation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.